fda compounding semaglutide news september 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Warns on Certain Forms

Glutathione might inhibit the effects of cerebral infarction and enhance antiapoptotic signaling after ischemic stroke, suggesting that GSH may be a potent therapeutic antioxidant that can attenuate severe pathologies after ischemic stroke, and stimulating GSH synthesis through administration of GSH precursors and micronutrients like selenium can optimize GSH and GSH peroxidase for optimal antioxidant defense in cerebral ischemia (155, 156)

Shockwave therapy improves blood flow, breaks down scar tissue, and supports tissue regeneration

Strategies for the enrichment and selection of genetically modified cells

For example, certain peptides prompt fibroblasts (cells responsible for producing collagen) to increase their activity, leading to firmer, smoother skin

It will be the first glimpse of VK2735s durability profile outside the acute dosing window, and it directly informs how Viking positions the subcutaneous program against the existing injectable standard, represented by tirzepatide, which received FDA approval for chronic weight management in November 2023